Related Experiment Video
Updated: Apr 23, 2026
08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.5K
Is personalized medicine achievable in obstetrics?
Sara K Quinney1, Avinash S Patil1, David A Flockhart2
1Department of Obstetrics and Gynecology and Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
Seminars in Perinatology
|October 6, 2014
Summary
Personalized medicine offers tailored treatments by considering genetics and environment. However, its application in obstetrics is limited, despite potential benefits for pregnant patients.
Area of Science:
- Obstetrics
- Pharmacogenomics
- Personalized Medicine
Background:
- Personalized medicine aims to optimize drug therapy based on individual pharmacogenomic profiles and environmental factors.
- Pregnancy involves significant physiological changes that can alter drug efficacy, necessitating tailored treatment approaches.
- Current research on personalized medicine in obstetrics is scarce, hindering its clinical adoption.
Purpose of the Study:
- To explore the potential utility of personalized medicine in obstetric care.
- To discuss the application of personalized medicine for managing pain, hypertension, and preterm labor in pregnant patients.
- To identify barriers to implementing pharmacogenetic testing in obstetrics.
Main Methods:
- Literature review on personalized medicine principles.
- Analysis of physiological changes during pregnancy affecting drug response.
- Discussion of pharmacogenetic applications in common obstetric conditions.
Main Results:
- Personalized medicine holds promise for optimizing treatment of pain, hypertension, and preterm labor in obstetric patients.
- Evidence of analytical validity, clinical validity, and clinical utility is crucial for adopting pharmacogenetic testing.
- Significant impediments exist in integrating personalized medicine into routine obstetrical care.
Conclusions:
- Personalized medicine has the potential to improve obstetric care outcomes.
- Further research and evidence generation are needed to overcome barriers to clinical implementation.
- Tailored pharmacogenetic approaches are essential for safe and effective medication use during pregnancy.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:50Combination Therapies and Personalized Medicine
1.5K
1.5K
01:21Intrauterine Drug Delivery Systems
161
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
161
01:29Pharmacogenomics: Identification of New Drug Targets
113
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
01:29Pharmacogenetics and Pharmacogenomics: Overview
236
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
236
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
155
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
155